AstraZeneca
AZN · NYSE
Bulios Fair Price
$154.82
3.3% downside
Trenutna cena
$160.16
Po podatkih Bulios Fair Price se delnica AZN trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
AstraZeneca (AZN) is a British-Swedish pharmaceutical company specializing in the research, development, and production of drugs for a wide range of therapeutic areas, including oncology, cardiovascular, respiratory, and immunological diseases. The company is known for its emphasis on scientific innovation and global healthcare initiatives, enabling it to bring new treatment options to patients worldwide. AstraZeneca also invests in the development of biologics and personalized medicine to improve treatment efficacy and outcomes. AstraZeneca (AZN) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on research, innovation, and a broad therapeutic portfolio.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Pascal Claude Roland Soriot
Employees
96,100
Headquarters
Cambridge
Prihajajoči dogodki
Earnings
Upcoming earnings report